LD-2 disclosure · 1st Quarter - Report
TEVA PHARMACEUTICALS USA
Client
- Description
- Generic and biosimilar manufacturer.
- Location
- District of Columbia · United States of America
Registrant
- Description
- Government Relations Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesHealth Issues
Issues surrounding US Pharmaceutical supply chain. Issues surrounding the generic drug and biosimilar user free agreements. Issues surrounding the regulation of complex generic drugs. HHS and National Security Council for agencies.
LobbyistsBRIAN SUTTER · THOMAS WHARTON · EMILY ELIZABETH WILKINSON-HOLLAND
Covered position (BRIAN SUTTER): Staff Dir. W&M Health subcommittee, Chairman Dave Camp April'13-Dec'14. Professional Staff, W&M Health subcommittee, Chairman Dave Camp, Jan'11-April'13. Leg Dir. Rep Dave Camp, May'08-Jan'11. Leg Asst Rep Dave Camp, Feb'03-May'08. Staff Ast July'02
Covered position (THOMAS WHARTON): Health Legislative Assistant - Senator Joe Lieberman. May 2011 - June 2012 Senior Legislative Assistant - Congressman Dan Boren. July 2008 - June 2011
Covered position (EMILY ELIZABETH WILKINSON-HOLLAND): Staff -Rep. Price (2010-11), LA: Rep. Grimm (2011-12), Rep. Black (2012-13), Sen.Vitter (2013-2015), Sen. Heller (2015-17), Policy Adv. to the Sec.- Dept of HHS (3/2017-8/2017), Sr Advisor to Administrator - Ctrs for Medicare & Medicaid (8/17- 5/19)
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
Issues surrounding Medicare reimbursement of generic drugs and biosimilars. Issues relating to the impact of prescription drug negotiation on generic drugs.
LobbyistsBRIAN SUTTER · THOMAS WHARTON · EMILY ELIZABETH WILKINSON-HOLLAND